SPH Notice - Masfen Securities Limited (‘MSL’)

1
Disclosure of beginning to have substantial holding
Section 276, Financial Markets Conduct Act 2013
To NZX Limited
and
To Pacific Edge Limited (PEB)
Date this disclosure made: 14 August 2025
Date on which substantial holding began: 13 August 2025
Substantial product holder(s) giving disclosure
Full name(s): Masfen Securities Limited (‘MSL’), together with Peter Masfen, Anatole
Masfen and Raphael Yan (and/or interests associated with them)
Summary of substantial holding
Class of quoted voting products: Ordinary shares in Pacific Edge Limited
Summary for Masfen Securities Limited (‘MSL’), together with Peter Masfen, Anatole
Masfen and Raphael Yan (and/or interests associated with them)
For this disclosure,—
(a) total number held in class: 80,295,578
(b) total in class: 1,021,510,460
(c) total percentage held in class: 7.86%
Details of relevant interests
Details for The Opito Trust
Nature of relevant interest(s): Beneficial owner of the ordinary shares in PEB, whose legal
owner is MSL
For that relevant interest,—
(a) number held in class: 59,320,050
(b) percentage held in class: 5.81%
(c) current registered holder(s): Masfen Securities Limited
(d) registered holder(s) once transfers are registered: Masfen Securities Limited
For a derivative relevant interest, also—
(a) type of derivative: not applicable
(b) details of derivative: not applicable

2
(c) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: not applicable

Details for The Masfen Foundation
Nature of relevant interest(s): Beneficial owner of the ordinary shares in PEB, whose legal
owner is MSL
For that relevant interest,—
(a) number held in class: 20,801,328
(b) percentage held in class: 2.04%
(c) current registered holder(s): Masfen Securities Limited
(d) registered holder(s) once transfers are registered: Masfen Securities Limited
For a derivative relevant interest, also—
(a) type of derivative: not applicable
(b) details of derivative: not applicable
(c) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: not applicable

Details for Apollo Holdings Limited
Nature of relevant interest(s): Beneficial owner and registered holder of the ordinary
shares in PEB
For that relevant interest,—
(a) number held in class: 174,200
(b) percentage held in class: 0.02%
(c) current registered holder(s): Apollo Holdings Limited
(d) registered holder(s) once transfers are registered: Apollo Holdings Limited
For a derivative relevant interest, also—
(a) type of derivative: not applicable
(b) details of derivative: not applicable
(c) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: not applicable

3

Details of transactions and events giving rise to substantial holding
Details of the transactions or other events requiring disclosure: Acquisition of shares under
placement completed on 30 May 2025 and issue of Shares to Directors, as approved by
shareholders on 6 August 2025.
Additional information
Address(es) of substantial product holder(s): C/- Artemis Capital, Level 35, Vero Centre,
48 Shortland Street, Auckland
Contact details: Philip Talacek | 027 561 4849 | philip@artemiscapital.co.nz
Nature of connection between substantial product holders: Common directors and/or
trustees and beneficial ownership
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: not applicable
Disclosure has effect for purposes of directors’ and senior managers’ disclosure
Anatole Masfen is also a director of Pacific Edge Limited. This disclosure also constitutes
disclosure for the purposes of the directors’ and senior managers’ disclosure obligations.
Certification
I, Philip Talacek, certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make this disclosure
by all persons for whom it is made.